Page last updated: 2024-09-03

fk 633 and fibrinogen

fk 633 has been researched along with fibrinogen in 5 studies

Compound Research Comparison

Studies
(fk 633)
Trials
(fk 633)
Recent Studies (post-2010)
(fk 633)
Studies
(fibrinogen)
Trials
(fibrinogen)
Recent Studies (post-2010) (fibrinogen)
190134,4771,7077,083

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, T; Cox, D; Motoyama, Y; Seki, J; Senzaki, K; Takasugi, H; Tanaka, A1
Fujiwara, H; Tanaka, A1
Aoki, T; Honda, S; Okubo, M; Seki, J; Senzaki, K; Takahashi, F; Takasugi, H; Tanaka, A; Tomiyama, Y1
Cox, D; Seki, J1
Arai, M; Honda, S; Kashiwagi, H; Kato, H; Kiyoi, T; Kosugi, S; Kurata, Y; Matsuzawa, Y; Tadokoro, S; Tomiyama, Y1

Other Studies

5 other study(ies) available for fk 633 and fibrinogen

ArticleYear
The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIB/IIIA antagonist.
    Thrombosis research, 1996, Feb-15, Volume: 81, Issue:4

    Topics: Animals; Bleeding Time; Blood Platelets; Cell Adhesion; Cells, Cultured; Coronary Circulation; Dipeptides; Dogs; Endothelium, Vascular; Fibrinogen; Fibrinolytic Agents; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins

1996
Quantitative structure-activity relationship study of fibrinogen inhibitors, [[4-(4-amidinophenoxy)butanoyl]aspartyl]valine (FK633) derivatives, using a novel hydrophobic descriptor.
    Journal of medicinal chemistry, 1996, Dec-06, Volume: 39, Issue:25

    Topics: Dipeptides; Fibrinogen; Humans; Platelet Aggregation Inhibitors; Structure-Activity Relationship

1996
Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:6

    Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Apyrase; Aspirin; Blood Platelets; Calcium; Cyclooxygenase Inhibitors; Dipeptides; Fibrinogen; Humans; Ion Transport; Peptide Fragments; Phenylacetates; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Signal Transduction; Sulfonamides; Thrombin; Thromboxane A2; Thromboxane B2; Tirofiban; Tyrosine

1998
Characterization of the binding of FK633 to the platelet fibrinogen receptor.
    Thrombosis research, 1998, Aug-01, Volume: 91, Issue:3

    Topics: Binding Sites; Binding, Competitive; Blood Platelets; Dipeptides; Fibrinogen; Fibrinolytic Agents; Humans; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex

1998
A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects.
    Blood, 2003, May-01, Volume: 101, Issue:9

    Topics: Adult; Allosteric Regulation; Amino Acid Substitution; Blood Platelets; Clot Retraction; Codon; Dipeptides; Female; Fibrinogen; Heterozygote; Humans; Ligands; Mutation, Missense; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Point Mutation; Polymorphism, Restriction Fragment Length; Protein Binding; Protein Structure, Tertiary; Recombinant Fusion Proteins; RNA, Messenger; Solubility; Structure-Activity Relationship; Thrombasthenia; Transfection

2003